Antibodies fight infection by recognizing a virus’s spike protein, and the omicron variant has raised concerns over the number of mutations on its spike protein, when compared to the delta variant.
Marion Pepper, MD, interim chair of UW Medicine’s immunology labs, said their efforts are focused on whether cells from people with immunity to other strains can respond to the new one.
“What we want to know — what are the changes in this new variant that are going to be dramatic, such that [the] immune system can no longer recognize those shapes?” Dr. Pepper said, according to the report.
UW labs will test the body’s response to both omicron viral bodies and other, harmless viruses with omicron’s spike protein attached, according to the report.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
